Xtant Medical Holdings, Inc.
XTNT
$0.54
-$0.01-1.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.68% | 19.04% | 18.26% | 18.05% | 12.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.68% | 19.04% | 18.26% | 18.05% | 12.11% |
| Cost of Revenue | -5.72% | -3.16% | -2.06% | 19.77% | 41.18% |
| Gross Profit | 10.80% | 34.86% | 30.69% | 17.00% | -6.49% |
| SG&A Expenses | 4.92% | -2.92% | -8.61% | -7.45% | -15.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.28% | -3.15% | -6.39% | 1.59% | 4.64% |
| Operating Income | 49.84% | 167.28% | 256.96% | 130.63% | 50.55% |
| Income Before Tax | 150.83% | 131.54% | 199.48% | 100.76% | 15.62% |
| Income Tax Expenses | 7,238.10% | 314.52% | 608.33% | -136.76% | -96.36% |
| Earnings from Continuing Operations | 101.80% | 126.04% | 191.95% | 101.32% | 26.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 101.80% | 126.04% | 191.95% | 101.32% | 26.45% |
| EBIT | 49.84% | 167.28% | 256.96% | 130.63% | 50.55% |
| EBITDA | 219.21% | 236.91% | 397.38% | 186.69% | 73.68% |
| EPS Basic | 102.00% | 125.27% | 186.15% | 101.18% | 39.58% |
| Normalized Basic EPS | 39.52% | 130.43% | 192.93% | 100.48% | 41.23% |
| EPS Diluted | 100.00% | 123.50% | 166.67% | 101.18% | 39.58% |
| Normalized Diluted EPS | 43.55% | 128.26% | 186.96% | 100.48% | 41.23% |
| Average Basic Shares Outstanding | -11.64% | 3.41% | 6.94% | 6.81% | 21.71% |
| Average Diluted Shares Outstanding | -4.92% | 11.31% | 14.05% | 10.09% | 21.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |